NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000754

Registered date:28/06/2007

Study on the efficacy of alternate day mizoribine pulse therapy for lupus nephrits

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedlupus nephritis
Date of first enrollment2007/05/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)mizoribine (5mg/kg, maximum 300mg/day), alternate day

Outcome(s)

Primary Outcomerenal function, urinary protein, relapse
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1)Pregnant women or lactating mothers 2)Patients having complications such as marrow suppression, infectious diseases, ulcer disease 3)GFR < 30 ml/min 4)Patients with allergy with Mizoribin

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail kidney@md.tsukuba.ac.jp
Affiliation Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,Univ. of Tsukuba Division of Nephrology
scientific contact
Name Kunihiro Yamagata
Address 1-1-1,Ten-nodai,Tsukuba,Ibaraki Japan
Telephone
E-mail
Affiliation Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,University of Tsukuba Division of Nephrology